Clinical Trial Update: The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating semaglutide versus standard weight management for weight reduction and change in intracranial pressure in new-onset idiopathic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Intracranial Hypertension
• Obesity
• Pseudotumor Cerebri Syndrome

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Rigmor Højland Jensen | Conditions: Idiopathic Intracranial Hypertension, Intracranial Pressure | Phase 4 | Status: COMPLETED